Top Markets
Coin of the day
Emcure Pharmaceuticals Ltd. Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

EMCURE
株式のランク #4302
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
株価
$20.55
時価総額
$3.90B
変化(1日)
0.83%
変化(1年)
22.65%
IN
取引 Emcure Pharmaceuticals Ltd. (EMCURE)

カテゴリー

Emcure Pharmaceuticals Ltd.(EMCURE)の配当履歴
Emcure Pharmaceuticals Ltd.(証券コード:EMCURE)は合計で0回の配当を行いました。
すべての配当の合計(株式分割調整済み)は:0.00
配当利回り(TTM):0
2026から2026までのEmcure Pharmaceuticals Ltd.(EMCURE)の配当履歴
年間配当支払い
配当(株式分割調整済み) 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴